IP Verse

Abbisko Therapeutics competitive analysis

Loading summary...

Latest patents of Abbisko Therapeutics opposed by its competitors

Explore Abbisko Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3632907
Feb 28, 2024N-(Azaaryl)Cyclolactam-1-Carboxamide Derivative, Preparation Method Therefor, And Use Thereof1

Latest publications and patents of Abbisko Therapeutics New

Explore the latest publications and patents granted to Abbisko Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Abbisko Therapeutics

EP3632907
Feb 28, 2024N-(Azaaryl)Cyclolactam-1-Carboxamide Derivative, Preparation Method Therefor, And Use ThereofGranted And Under Opposition

Latest PTAB cases involving Abbisko Therapeutics

Discover the latest PTAB cases involving Abbisko Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Abbisko Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ABBISKO THERAPEUTICS - 1 - -
DECIPHERA PHARMACEUTICALS12 - -